Clinical Trials Directory

Trials / Completed

CompletedNCT01483495

Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study

Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry

Status
Completed
Phase
Study type
Observational
Enrollment
78 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The brain is such a metabolically active organ that it consumes about 20% of oxygen burned every minute by an average adult even though it only contributes about 2% of the body weight. As a result, the brain produces a disproportionately high amount of CO2 every minute in comparison with the rest of the body.

Detailed description

The researcher can use Diffuse Optical Spectroscopy Imaging, cerebral non-invasive oximetry instrument, to determine cerebrovascular reactivity during surgery procedure. Specifically, the cerebral tissue O2 saturation can measure by Diffuse Optical Spectroscopy Imaging can use for cerebral blood flow in the evaluation of cerebrovascular reactivity. Adequate brain perfusion is critical not only to supply oxygen and nutrients but also to wash out metabolic end products including CO2. Blood flow depends on perfusion pressure and vascular bed resistance. It is well known that multiple physiological and pathological factors affect cerebral vasculature, and the resistance to blood flow. The cerebrovascular responsiveness to those factors determines how well the brain can maintain and adjust its perfusion.

Conditions

Interventions

TypeNameDescription
DEVICEDiffuse optical spectroscopyDiffuse Optical Spectroscopy Imaging Cerebrovascular Reactivity

Timeline

Start date
2011-12-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-12-01
Last updated
2022-11-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01483495. Inclusion in this directory is not an endorsement.